HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hans Denison Selected Research

Hemorrhage

1/2023Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial.
1/2022Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack.
11/2021Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
1/2021Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial.
12/2020Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin.
1/2020Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.
10/2019The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design.
1/2019Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.
1/2018Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.
9/2017Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hans Denison Research Topics

Disease

17Stroke (Strokes)
01/2023 - 12/2015
15Ischemic Stroke
01/2023 - 12/2015
15Transient Ischemic Attack
01/2022 - 12/2015
13Hemorrhage
01/2023 - 07/2016
11Gastroesophageal Reflux (GERD)
01/2016 - 08/2010
7Heartburn (Pyrosis)
10/2014 - 12/2007
5Myocardial Infarction
10/2019 - 07/2016
4Pathologic Constriction (Stenosis)
12/2020 - 01/2017
3Brain Ischemia (Cerebral Ischemia)
10/2019 - 07/2016
3Peptic Esophagitis (Reflux Esophagitis)
09/2012 - 12/2007
2Atherosclerosis
12/2020 - 01/2017
2Embolic Stroke
01/2017 - 07/2016
2Paresthesia (Dysesthesia)
01/2016 - 08/2010
2Non-Erosive Reflux Disease
05/2014 - 09/2012
1Vascular Diseases (Vascular Disease)
01/2018
1Hemorrhagic Stroke
09/2017
1Brain Infarction
09/2017
1Intracranial Hemorrhages (Intracranial Hemorrhage)
07/2016
1Dyspepsia (Indigestion)
09/2012
1Pain (Aches)
09/2012
1Headache (Headaches)
08/2010
1Esophagitis
12/2007

Drug/Important Bio-Agent (IBA)

18Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2023 - 12/2015
18TicagrelorIBA
01/2023 - 12/2015
6Proton Pump InhibitorsIBA
01/2016 - 09/2011
5lesogaberanIBA
01/2016 - 08/2010
5AZD0865IBA
05/2014 - 12/2007
5Esomeprazole (Nexium)FDA Link
05/2014 - 12/2007
4AcidsIBA
05/2014 - 12/2007
2Aminobutyrates (Aminobutyric Acid)IBA
01/2016 - 09/2013
1Clopidogrel (Plavix)FDA Link
01/2020
1GABA-B Receptor AgonistsIBA
01/2016
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
12/2015
1PotassiumIBA
06/2012

Therapy/Procedure

14Therapeutics
01/2021 - 09/2011
1Thrombectomy
01/2020